Literature DB >> 2570155

Linkage analysis in the spinal muscular atrophy type of facioscapulohumeral disease.

T Siddique1, H Roper, M A Pericak-Vance, J Shaw, K L Warner, W Y Hung, K L Phillips, P Lunt, W J Cumming, A D Roses.   

Abstract

Facioscapulohumeral disease is probably a heterogeneous disorder. We have ascertained and sampled two multigeneration families with the neurogenic form of this disorder, considered to be a type of spinal muscular atrophy (FSHSMA). The two families have 36 affected members. Linkage studies with 10 expressed and seven DNA restriction fragment length polymorphism (RFLP) markers failed to show significant linkage (Zmax greater than or equal to 3.00). However, two areas of probable linkage were defined on chromosomes 1p and 4q with the markers MNS (Zmax = 1.47 at theta max = 0.10) and PGM1 (Zmax = 0.94 at theta max = 0.001) respectively. We are using additional RFLPs from these and other areas of the human genome to screen these families for linkage to FSHSMA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570155      PMCID: PMC1015668          DOI: 10.1136/jmg.26.8.487

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  [Specific type of Landouzy-Dejerine muscular dystrophy].

Authors:  P BENASSI; R CANESTRARI
Journal:  Riv Patol Nerv Ment       Date:  1953

2.  Report of the committee on human gene mapping by recombinant DNA techniques.

Authors:  P L Pearson; K K Kidd; H F Willard
Journal:  Cytogenet Cell Genet       Date:  1987

3.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  Familial "mitochondrial" myopathy. A myopathy associated with disordered oxidative metabolism in muscle fibres. 1. Clinical, electrophysiological and pathological findings.

Authors:  P Hudgson; W G Bradley; M Jenkison
Journal:  J Neurol Sci       Date:  1972-07       Impact factor: 3.181

5.  Inflammatory myopathy with facioscapulohumeral distribution.

Authors:  T L Munsat; D Piper; P Cancilla; J Mednick
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

6.  Polymyositis with facioscapulohumeral distribution.

Authors:  T L Rothstein; C B Carlson; S M Sumi
Journal:  Arch Neurol       Date:  1971-10

7.  Evidence against location of the gene for facioscapulohumeral muscular dystrophy on the distal long arm of chromosome 14.

Authors:  P W Lunt; J G Noades; M Upadhyaya; M Sarfarazi; P S Harper
Journal:  J Neurol Sci       Date:  1988-12       Impact factor: 3.181

8.  Neurogenic atrophy simulating facioscapulohumeral dystrophy. A dominant form.

Authors:  G M Fenichel; E S Emery; P Hunt
Journal:  Arch Neurol       Date:  1967-09

9.  Chronic spinal muscular atrophy of facioscapulohumeral type.

Authors:  T Furukawa; Y Toyokura
Journal:  J Med Genet       Date:  1976-08       Impact factor: 6.318

10.  The poliovirus sensitivity (PVS) gene is on chromosome 19q12----q13.2.

Authors:  T Siddique; R McKinney; W Y Hung; R J Bartlett; G Bruns; T K Mohandas; H H Ropers; C Wilfert; A D Roses
Journal:  Genomics       Date:  1988-08       Impact factor: 5.736

  10 in total
  4 in total

1.  A closely linked DNA marker for facioscapulohumeral disease on chromosome 4q.

Authors:  M Upadhyaya; P W Lunt; M Sarfarazi; W Broadhead; J Daniels; M Owen; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

2.  A clinically homogeneous group of families with facioscapulohumeral (Landouzy-Déjérine) muscular dystrophy: linkage analysis of six autosomes.

Authors:  S J Jacobsen; E S Diala; B V Dorsey; M B Rising; R Graveline; K Falls; P Schultz; C Hogan; K Rediker; C D'Amico
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

3.  An exclusion map for facioscapulohumeral (Landouzy-Déjérine) disease.

Authors:  M Sarfarazi; M Upadhyaya; G Padberg; M Pericak-Vance; T Siddique; G Lucotte; P Lunt
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

4.  Genetic counselling in facioscapulohumeral muscular dystrophy.

Authors:  P W Lunt; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.